The Tricky Business of Getting Through US Customs
This article was originally published in SRA
Executive Summary
In the US, public and political focus on pharmaceutical imports is at an all-time high. People have been frightened by several high-profile recalls of tainted consumer goods from abroad and are confused by warnings that they are taking their lives into their own hands if they buy cheaper drugs from other countries – even Canada. In Congress, some politicians are trying to strengthen the law to make it harder to import drugs1, while others are working to relax it so that drug importation is not the exclusive right of pharmaceutical manufacturers2.
You may also be interested in...
Global medtech alliance approves six new member associations
An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.
Global medtech alliance approves six new member associations
An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.
US FDA scrutiny of DTC genetic tests continues
The US FDA's devices unit has written to three genetic testing companies warning them that they may be marketing their products and services without clearance by the agency.